Back

Effect of sodium-glucose co-transporter inhibitors on arterial stiffness in patients with type 2 diabetes mellitus

26 August 2023 (13:15 - 13:50)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Jozsef Szigeti

Mohacs (Hungary)

5 More presentations in this session

Presentation thumbnail
Sex differences in the clinical profile of individuals with prediabetes and type 2 diabetes mellitus in the general population - results from the Gutenberg Health Study
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Time to act: the challenge of high incidence of diabetes and prediabetes in patients admitted with different cardiovascular diseases phenotypes
Doctor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video
Presentation thumbnail
Modifications of short-term heart rate variability in metabolic syndrome: a systematic review and meta-analysis
Mr J. Ortiz-Guzman (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Metabolic syndrome and long-term heart rate variability: a systematic review and meta-analysis
Mr J. Ortiz-Guzman (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study
Doctor D. Garcia Vega (Ourense, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (2)

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report.
thumbnail
Congress Presentation
Parallel improvement of arterial stiffness with weight loss following intensification of antidiabetic treatment
thumbnail
Congress Presentation
Effects of SGLT-2i and GLP-1RA in vascular function parameters: the impact of the weight loss

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources